Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooke E Howitt

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
Gynecologic Oncology|May 8, 2026
Expression of the antibody-drug conjugate targets TROP2, CLDN6, B7-H3, and DLL3 in mesonephric-like adenocarcinoma of the female genital tractXiaoming Zhang, Jahanbanoo Shahryari, Leandra G Kingsley, et al.
Journal of Clinical Pathology|January 26, 2019
International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcomeAnjelica Hodgson, Ekaterina Olkhov-Mitsel, Brooke E Howitt, et al.
The American Journal of Surgical Pathology|December 6, 2012
Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificityBrooke E Howitt, Marisa R Nucci, Ronny Drapkin, et al.
The American Journal of Surgical Pathology|November 30, 2018
A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the EndometriumDavid L Kolin, Danielle C Costigan, Fei Dong, et al.
Nature Reviews. Clinical Oncology|June 17, 2026
Antibody-drug conjugates in gynaecological cancers: opportunities and challengesKathleen N Moore, Oladapo O Yeku, Brooke E Howitt, et al.
Human Pathology|October 20, 2018
Clinicopathological and immunohistochemical features of uterine adenomyomatous polypsKyle C Strickland, Liping Yuan, Bradley J Quade, et al.
Gynecologic Oncology|December 4, 2018
The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinomaThing Rinda Soong, Brooke E Howitt, Neil Horowitz, et al.
Histopathology|June 27, 2022
A Subset of SMARCB1 (INI-1)-deficient vulvar neoplasms express germ cell markersPhoebe M Hammer, David L Kolin, Gregory W Charville, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2023
PTEN Deficiency in Tubo-Ovarian High-Grade Serous Carcinoma is Associated with Poor Progression-Free Survival and is Mutually Exclusive with CCNE1 AmplificationXiaoming Zhang, Aihui Wang, Lucy Han, et al.
The American Journal of Surgical Pathology|May 18, 2016
Unusual Mismatch Repair Immunohistochemical Patterns in Endometrial CarcinomaJaclyn C Watkins, Marisa R Nucci, Lauren L Ritterhouse, et al.
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
Gynecologic Oncology|May 8, 2026
Expression of the antibody-drug conjugate targets TROP2, CLDN6, B7-H3, and DLL3 in mesonephric-like adenocarcinoma of the female genital tractXiaoming Zhang, Jahanbanoo Shahryari, Leandra G Kingsley, et al.
Journal of Clinical Pathology|January 26, 2019
International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcomeAnjelica Hodgson, Ekaterina Olkhov-Mitsel, Brooke E Howitt, et al.
The American Journal of Surgical Pathology|December 6, 2012
Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificityBrooke E Howitt, Marisa R Nucci, Ronny Drapkin, et al.
The American Journal of Surgical Pathology|November 30, 2018
A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the EndometriumDavid L Kolin, Danielle C Costigan, Fei Dong, et al.
Nature Reviews. Clinical Oncology|June 17, 2026
Antibody-drug conjugates in gynaecological cancers: opportunities and challengesKathleen N Moore, Oladapo O Yeku, Brooke E Howitt, et al.
Human Pathology|October 20, 2018
Clinicopathological and immunohistochemical features of uterine adenomyomatous polypsKyle C Strickland, Liping Yuan, Bradley J Quade, et al.
Gynecologic Oncology|December 4, 2018
The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinomaThing Rinda Soong, Brooke E Howitt, Neil Horowitz, et al.
Histopathology|June 27, 2022
A Subset of SMARCB1 (INI-1)-deficient vulvar neoplasms express germ cell markersPhoebe M Hammer, David L Kolin, Gregory W Charville, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2023
PTEN Deficiency in Tubo-Ovarian High-Grade Serous Carcinoma is Associated with Poor Progression-Free Survival and is Mutually Exclusive with CCNE1 AmplificationXiaoming Zhang, Aihui Wang, Lucy Han, et al.
The American Journal of Surgical Pathology|May 18, 2016
Unusual Mismatch Repair Immunohistochemical Patterns in Endometrial CarcinomaJaclyn C Watkins, Marisa R Nucci, Lauren L Ritterhouse, et al.
Pageof 17